BDBM50110453 2-(1,4-oxazinan-4-yl)ethyl 5-{[1-{3-[6-(2-chlorophenyl)-1,4-dimethyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-9-ylmethyl]phenyl}-1-(3-pyridyl)-(E)-methylideneamino]-oxy}-pentanoate::CHEMBL164758

SMILES CC1N=C(c2c3CCN(Cc4cccc(c4)C(=N/OCCCCC(=O)OCCN4CCOCC4)\c4cccnc4)Cc3sc2-n2c(C)nnc12)c1ccccc1Cl

InChI Key InChIKey=WZRBVVHQLFBQKT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50110453   

TargetThromboxane-A synthase(Human)
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50110453(2-(1,4-oxazinan-4-yl)ethyl 5-{[1-{3-[6-(2-chloroph...)
Affinity DataIC50: 151nMAssay Description:In vitro inhibition of thromboxane synthase (TXA2) in human platelet microsomes [reduced formation of TXB2 from prostaglandin H2(PGH2)]More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed